Shares of Pure Storage, Inc. (NYSE:PSTG) rose sharply in today's pre-market trading following better-than-expected first-quarter financial results. Pure Storage reported quarterly earnings of 32 cents per share, which beat the analyst consensus estimate of 21 cents. Quarterly sales clocked in at $693.479 million, beating the analyst consensus estimate of $680.972 million, according to data from Benzinga Pro. Pure Storage shares jumped 10.5% to $69.60 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Smart for Life, Inc. (NASDAQ:SMFL) rose 60.5% to $6.27 in today's pre-market trading after gaining around 17% on Wednesday. Smart
New Name Reflects Continued Evolution as an AI-Driven Robotics Company with a Strong IP Position
CRO Expands Clinical Capabilities, Accelerating Product Pipeline Development and Commercialization Opportunities
AUSTIN, TX / ACCESSWIRE / September 11, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced an upsize of its previously announced continuous offering of units from $10 million to $12.5 million of units. Each unit consists of (a) one share of the Company's 8.00% Series D Convertible Cumulative Preferred Stock (the "Series D Preferred Stock") and (b) one common stock purchase warrant to purchase one share of its common stock, $0.001 par value per share (the "Common Stock").The units have no stand-alone rights and will not be certified or issued
Submitted FDA 510(k) Application and Passed FDA Administrative Review for the mBôs TKA SystemSecured Initial Strategic Multicenter Clinical Trial Collaboration with Shalby LimitedManagement to Host Business Update Conference Call Today at 4:30 p.m. Eastern Time AUSTIN, TX / ACCESSWIRE / August 14, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, has reported its financial and operational results for the second quarter ended June 30, 2024.Second Quarter 2024 and Subsequent Operational HighlightsSubmitted a 510(k) premarket filing to the U.S. Food and Drug
Clinical Trial Collaboration Follows 510(k) Submission and Passing of FDA Administrative Review; Preludes Planned International Launch for the mBȏs TKA SystemStrategic Partner Shalby is Recognized as one of the Leading Institutions for Orthopedic Surgeries Worldwide, Performing Over 14,000 Annual Knee Replacement Surgeries Globally AUSTIN, TX / ACCESSWIRE / August 12, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced its strategic collaboration with Shalby Limited (NSE:SHALBY) ("Shalby"), a global muti-specialty hospital chain and one of In
AUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, will hold a business update conference call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time in conjunction with its reported financial results for the second quarter ended June 30, 2024 and to discuss key milestones. A press release detailing these results will be issued prior to the call.Monogram CEO Ben Sexson and CFO Noel Knape will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, wh
Verification and Validation Testing Expected to be Largely Complete in Q2 2024; 510(k) Submission with FDA Accelerated for Second Half of 2024Engaged Contract Research Organization to Oversee mBôs Robot Clinical Trial Activities Outside the U.S.Management to Host Business Update Conference Call on Wednesday, May 22 at 4:30 p.m. Eastern Time AUSTIN, TX / ACCESSWIRE / May 14, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, has reported its financial and operational results for the first quarter ended March 31, 2024.First Quarter 2024 and Subsequent Operati
AUSTIN, TX / ACCESSWIRE / March 20, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, today announced management will host a business update conference call on Thursday, March 21, 2024 at 5:00 p.m. Eastern time to discuss its results for the full fiscal year ended December 31, 2023, and will be providing regulatory updates, reviewing ongoing initiatives and technology strategy, and anticipated 2024 milestones.Monogram Chief Executive Officer Ben Sexson, Chief Medical Officer Doug Unis, MD, Chief Technology Officer Kamran Shamaei, and Chief Financial Officer Noel Knape w
4 - MONOGRAM ORTHOPAEDICS INC (0001769759) (Issuer)
8-K - Monogram Technologies Inc. (0001769759) (Filer)
424B5 - Monogram Technologies Inc. (0001769759) (Filer)
8-K - Monogram Technologies Inc. (0001769759) (Filer)
Collaboration to Provide Monogram with Technical Resources to Drive Development and Commercialization of mBôs SystemAUSTIN, TX / ACCESSWIRE / April 11, 2024 / Monogram Orthopaedics Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), a medical technology company focused on reconstructive joint procedures and surgical robotics, today announced it has joined NVIDIA Inception, a program designed to help companies evolve faster through cutting-edge technology and access to the latest technical resources from NVIDIA.NVIDIA Inception will help drive Monogram to help drive development of its mBôs robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation co